The acquisition is complementary to Biotage’s existing offering and allows us to meet the global trend of increasing awareness and concern of environmental issues, pollution and toxics.
Through the acquisition, Biotage will strengthen its position as a niched separations company within environmental applications and food safety, areas were Biotage currently is less well positioned. Together with Horizon, Biotage will be able to offer its global customers a more comprehensive portfolio of products. In addition, Biotage’s global direct sales reach is expected to accelerate Horizon’s business. The combined operations will be well positioned to capture global growth trends, such as growing demand for testing and purification of water and food.
Horizon Technology had 41 employees and sales of $8.2M in 2016. Their main customers are found in governmental agencies, petrochemical industries, food & beverage and pharma, as well as commercial laboratories.
TurboVap® in German
Biotage Acquires Horizon Technology
Extraction of Acidic Catecholamine Metabolites in Plasma Using ISOLUTE® SLE+ Prior to LC-MS/MS Analysis
Video Demonstration: Multi Racks for TurboVap®
Effective Purification of Peptides using Normal Phase Flash